Diabetes: Expanding the knowledge of types 1 and 2 diabetes reveals new drug targets - Sanford Burnham Prebys
Event

Diabetes: Expanding the knowledge of types 1 and 2 diabetes reveals new drug targets

Pamela Itkin-Ansari, PhD and Randal J. Kaufman, PhD

DateNov 17, 2020
Time1:00-2:00PM PT
Location
Zoom
Get Directions

Do you, or does someone you know, have diabetes? Then you’re probably aware that it’s hard work to get—and keep—diabetes under control. In addition, you know how important it is to get a handle on it to avoid a host of dangerous health complications.

Improved ways to prevent and treat diabetes would benefit the more than 400 million people worldwide living with the disease. Join us to learn about recent discoveries in Type 1 and Type 2 diabetes research, direct from our leading researchers. They will discuss how their collaboration opened up an entirely new approach to effectively manage diabetes, and how biomarkers may lead to early detection and stave off this chronic condition. Hear about breakthroughs—including how our scientists are identifying novel drug targets to treat diabetes.
 
A Q&A session will follow the presentation to provide you an opportunity to personally connect with our scientists and have your questions answered.

Don’t miss this chance to connect with our scientists and have your questions answered!
 

Event recording

pamela-itkin-ansari-phd_c_1-2


Pamela Itkin-Ansari, PhD

Adjunct Associate Professor

Development, Aging and Regeneration Program

Neuroscience and Aging Research Center


randal-kaufman-phd_c_1-2


Randal J. Kaufman, PhD

Director and Professor

Degenerative Diseases Program

Neuroscience and Aging Research Center